Recorded Chinese product: 新福菌素注射液新福菌素注射液

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

放线菌素D是一种在国家药监局注册认定的药品。该药品含有放线菌素d-23610a00等成分。

该药品关联的活性成分包括:放线菌素d。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:福州海王福药制药有限公司Chinese legal name: 福州海王福药制药有限公司。

您可以探索含有相同成分的其他药品:放线菌素d-23610a00成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 新福菌素注射液) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Manufacturers recorded for this product: 福州海王福药制药有限公司Chinese legal name: 福州海王福药制药有限公司.

Explore other medicines containing the same ingredient: 放线菌素d productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 新福菌素注射液Recorded Chinese product: 新福菌素注射液
  • 剂型Dosage form: 注射剂Injection
  • 规格Specification: 20ml:0.4mg20 mL:0.4 mg

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

生产企业Manufacturer

  • 福州海王福药制药有限公司Chinese legal name: 福州海王福药制药有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H20065737

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H20065737

Manufacturer

Chinese legal name: 福州海王福药制药有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

Protect from light and keep tightly closed.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H20065737

生产企业

福州海王福药制药有限公司(国产)

适应症

用于治疗恶性葡萄胎、绒毛膜上皮癌、肾母细胞瘤(Wilms瘤)、软组织肉瘤、尤文肉瘤(Ewing瘤)、恶性淋巴瘤、神经母细胞瘤、睾丸肿瘤等恶性肿瘤。

用法用量

1.静脉注射。剂量需依患者对本品的敏感度和临床使用方法而定。|2.全身性用药:一般剂量为每日300~400μg(每日6~10μg /kg),溶于5%葡萄糖溶液250~500ml中,行静脉滴注4~5小时,连续10~12天为1疗程,总剂量一般为3600~6000μg左右。间隔2周左右再用第二疗程,也可酌情减少给药日剂量,延长疗程周期。|3.联合用药:|(1)与长春新碱、阿霉素合用,治疗肾母细胞(Wilms)瘤;|(2)与环磷酰胺、长春碱、博来霉素、顺铂合用,治疗睾丸肿瘤;|(3)与阿霉素、环磷酰胺、长春新碱合用,治疗软组织肉瘤、尤文(Ewing)肉瘤;也可用于治疗恶性淋巴瘤的联合化疗方案中。|(4)与放射治疗联合应用,能提高肿瘤对放射治疗的敏感性,浓集并滞留于有核细胞内,妨碍放射修复。

不良反应

1.骨髓抑制:可出现白细胞、血小板明显下降,常在用药后7~14日出现。|2.胃肠道反应:表现为食欲不振、恶心、呕吐、腹泻,少数有口腔溃疡。|3.局部反应:静注可引起静脉炎,漏到血管外可引起组织坏死。|4.其他:少数患者出现头晕、乏力、骨关节酸痛、肝功能损害、心电图改变、脱发等。

禁忌

对本品任何成分过敏的患者。

注意事项

1.本品可能使尿及血内尿酸升高。|2.水痘或最近患过水痘患者不宜用本品。|3.下列情况应慎用:骨髓造血功能低下、有痛风病史、肝功能损害、感染、有尿酸盐性肾结石病史者。|4.用药期间应定期检查周围血象及肝、肾功能。|5.静注时注意不要漏出血管外,以免引起局部反应。|6.本药与放射治疗同用,能增强肿瘤对放疗的敏感性,但有可能在放疗部位出现新的炎症而产生“放疗再现”皮肤改变,应予注意。

贮藏

遮光,密封保存。

规格

20ml:0.4mg

证据Evidence

  • 批准文号: 国药准字H20065737
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.